A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

We are pleased to complete the last subject visit in our Phase 1 trial of MBX 1416 in healthy adults and extend our sincere appreciation to the participants, investigators and clinical team for their ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.

What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which ...

Modern medical innovations continue to transform treatment approaches for chronic conditions, and Ozempic stands at the ...

The success of weight loss drugs like Ozempic heavily relies on the effect that they have in your brain, too, according to ...

More than a quarter of us have learned all we know about weight-loss jabs through social media, so GP Dr Bryony Henderson has helped clear up the myths and misunderstandings ...

In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...